Shares of ResMed Inc. RMD shed 2.71% to $232.98 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...
Hosted on MSN13d
ResMed Inc. Reports Changes in CDI and Security IssuancesResmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) just unveiled an update. ResMed Inc. has ...
ResMed Inc (RMD) reports a 10% revenue increase and significant margin expansion, driven by robust device sales and strategic global expansion.
Shares of ResMed Inc. RMD advanced 1.44% to $239.48 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6,115.07 and ...
ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...
If shares of ResMed (RMD) reach support, potential buyers may start to outbid each other. This could force the shares into an uptrend.
Brett Fishbin; Analyst; KeyBanc Capital Markets Inc. Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator ...
Wilsons analyst Shane Storey downgraded Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – Research Report) to a ...
Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...
13d
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – Research Report) received a Buy rating and price target from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback